Searched over 200M research papers
10 papers analyzed
These studies suggest that tumor growth can be influenced by mechanical factors, nutrient diffusion, cytological details, cellular behavior, tissue architecture, and immune system interactions, with growth patterns varying by cancer type and age of onset.
20 papers analyzed
The mechanics of tumor growth can be understood through the lens of Continuum Mechanics, where a tumor is treated as a growing soft tissue. This approach separates volumetric growth from mechanical response, describing growth as an increase in the mass of particles rather than their number. Tumor growth is heavily influenced by the availability of nutrients and chemical signals like growth factors, which diffuse through the growing material. This model has been applied to scenarios such as the homogeneous growth inside a rigid cylinder, mimicking ductal carcinoma, and the growth of multicell spheroids with non-homogeneous nutrient diffusion, leading to residual stresses due to inhomogeneous growth.
Methods to estimate tumor growth rates involve observing tumor volumes at two time points and fitting various growth models, including power law, exponential, Gompertz, and Spratt’s generalized logistic model. Despite biases in sample ascertainment, exponential growth patterns are evident in breast and liver cancers, while a 2/3 power law (surface growth) is observed in neurological cancers.
Malignant growths exhibit a unique type of nuclear division known as heterotype mitosis, characterized by a reduction in the number of somatic chromosomes. This type of division, typically associated with the formation of sexual elements, has been observed in cancer cells, suggesting a distinct cellular life stage termed the "maiotic phase." This phase includes heterotype and homotype mitoses, which are crucial for understanding the cellular dynamics of cancerous tissues.
Artificial propagation of cancer in mice, particularly through inoculations of Jensen’s tumor, has provided insights into the continuous or interrupted nature of cancerous proliferation. This experimental approach has revealed that not all inoculated animals develop tumors, and those that do exhibit varying sizes, highlighting the influence of experimental conditions on tumor cell proliferation. These findings are essential for understanding the nature of cancer and developing therapeutic strategies.
Research on malignant growth at the cellular level has shown that cancer cells, though generally stable, can undergo unexpected transformations. For instance, individual cells of Yoshida sarcoma and ascites hepatomas have been observed to fluctuate within certain limits, occasionally transforming from sarcoma to carcinoma morphology. This transformation can significantly reduce the growth speed of the tumors, indicating a dynamic cellular behavior within malignant growths.
The cancer stem cell hypothesis suggests that tumor growth is driven by a rare subpopulation of tumor cells. However, studies have shown that a high frequency of tumor cells can seed tumor growth when transplanted into histocompatible mice, challenging the notion that only rare cancer stem cells drive tumor growth. This discrepancy may be due to the limited adaptability of human tumor cells in foreign environments like immunocompromised mice.
Most papillary thyroid cancers are believed to originate in infancy and childhood, linked to the growth pattern of follicular cells. These cancers undergo three stages: initiation, progression, and escape. The early origin and limited growth potential of differentiated follicular cells suggest that many papillary thyroid cancers remain as micro-carcinomas with low growth rates, necessitating a reconsideration of treatment protocols and nomenclature for small papillary carcinomas.
Biomathematical models offer insights into the natural growth history of human neoplastic diseases, often limited by clinical observation spans. These models, which include geometric growth schemas, help extend our understanding of tumor growth beyond clinical limitations, providing a framework for predicting future tumor behavior.
The architecture of normal tissue significantly influences the evolutionary dynamics of cancer. Spatial constraints and cell mixing rates within the tissue determine the acquisition of functional mutations and genetic heterogeneity. This dynamic can lead to a transition from Darwinian premalignant growth to invasive neutral tumor growth, highlighting the role of tissue structure in cancer evolution.
The interaction between tumor cells and organ cells is crucial for tumor development. The "precancerous state" involves the degeneration of parenchymatous cells, which is essential for tumor growth in organs capable of inhibiting tumor proliferation. Conversely, in organs unable to inhibit tumor growth, the condition observed is a "postcancerous state," resulting from the mechanical or chemical injury caused by proliferating tumor cells. General resistance or immunity to cancer growth plays a more significant role than local conditions in determining susceptibility to tumor growth.
The study of cancerous growths encompasses various aspects, from mechanical models and growth rate estimation to cellular transformations and the influence of tissue architecture. Understanding these factors is crucial for developing effective therapeutic strategies and improving clinical outcomes for cancer patients.
Most relevant research papers on this topic